Lost Investment in Alexandria Real Estate Equities, Inc. (ARE)? Levi & Korsinsky Launches Securities Fraud Investigation

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alexandria Real Estate Equities, Inc. ("Alexandria Real Estate Equities, Inc.") (NYSE:ARE) concerning possible violations of federal securities laws. Alexandria issued a press release on October 27, 2025, reporting its financial results for […]

Did Alector, Inc. (ALEC) Mislead Investors? Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with

LRN ALERT: Ongoing Investigation Into Stride, Inc. – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers

JHX Investors Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit with the Schall Law Firm

(NYSE:JHX), LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against James Hardie Industries plc (“James Hardie” or “the Company”) (NYSE: JHX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm

(NYSE:BAX), LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

JHX Investors Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit with the Schall Law Firm

JHX Investors Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire November 07, 2025 LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against James Hardie Industries plc (“James Hardie” or

BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm

BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire November 07, 2025 LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE:

Did Sonic Automotive, Inc. (SAH) Mislead Investors? Levi & Korsinsky Investigates

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sonic Automotive, Inc. ("Sonic Automotive, Inc.") (NYSE:SAH) concerning possible violations of federal securities laws. Sonic Automotive reported its financial results for the third quarter of 2025 on October 23, 2025. Among other

Bell Canada to redeem Series M-41 debentures due March 2, 2026

Bell Canada (Bell) today announced it will redeem, on December 8, 2025, prior to maturity, all of its outstandingCdn $750 million principal amount of 3.55% Debentures, Series M-41, due March 2, 2026 (the Series M-41 Debentures). The Series M-41 Debentures will be redeemed at par, being a price equal to $1,000 per $1,000 of principal

Lost Money on Akebia Therapeutics, Inc. (AKBA)? Contact Levi & Korsinsky to Protect Your Rights

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion

Scroll to Top